Hyperfine (HYPR) to Release Earnings on Wednesday

Hyperfine (NASDAQ:HYPR) is expected to release its Q4 2025 results before the market opens on Wednesday, March 18th. Analysts expect Hyperfine to post earnings of ($0.08) per share and revenue of $5.30 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, March 18, 2026 at 4:30 PM ET.

Hyperfine Stock Performance

Hyperfine stock opened at $1.16 on Wednesday. Hyperfine has a one year low of $0.53 and a one year high of $2.22. The business has a fifty day moving average of $1.12 and a two-hundred day moving average of $1.20. The company has a market cap of $112.72 million, a P/E ratio of -2.23 and a beta of 1.09.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research note on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $1.28.

Institutional Trading of Hyperfine

A number of institutional investors have recently bought and sold shares of HYPR. EP Wealth Advisors LLC purchased a new position in shares of Hyperfine in the fourth quarter valued at $34,000. Millennium Management LLC purchased a new stake in shares of Hyperfine in the 4th quarter worth about $55,000. Cerity Partners LLC acquired a new stake in Hyperfine in the 4th quarter valued at about $59,000. XTX Topco Ltd grew its stake in Hyperfine by 47.9% in the 4th quarter. XTX Topco Ltd now owns 80,735 shares of the company’s stock valued at $79,000 after acquiring an additional 26,165 shares during the last quarter. Finally, Bridgeway Capital Management LLC grew its position in shares of Hyperfine by 50.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 119,700 shares of the company’s stock valued at $117,000 after purchasing an additional 40,000 shares during the last quarter. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.